MyFinsight
Home
Blog
About
Contact
Download
Download image
Finite-lived intangible
assets, gross
$596,321K
Subtotal, original cost
$32,627K
Inventories
$176,890K
Cash and cash
equivalents
$170,177K
Accounts receivable, net
$143,560K
Short-term investments
$112,635K
Income tax refunds and
deposits
$17,167K
Prepaid expenses and
other assets
$13,152K
Restricted short-term
investments
$2,200K
Restricted cash
$235K
Balance, original cost
$628,948K
Total current assets
$636,016K
Goodwill and intangible
assets, net
$565,965K
Property, plant, and
equipment, net
$310,567K
Operating lease
right-of-use assets
$42,931K
Deferred tax assets
$42,464K
Other assets
$31,135K
Finance lease
right-of-use assets
$221K
Accumulated amortization
$62,983K
Total assets
$1,629,299K
Total liabilities and
stockholders' equity
$1,629,299K
Total liabilities
$840,494K
Total stockholders'
equity
$788,805K
Treasury stock
$408,148K
Accumulated other
comprehensive loss
-$5,314K
Long-term debt, net of
current portion and...
$608,749K
Total current
liabilities
$158,156K
Long-term operating lease
liabilities, net of current...
$37,684K
Other long-term
liabilities
$29,979K
Long-term reserve for
income tax liabilities
$5,926K
Retained earnings
$666,881K
Additional paid-in capital
$535,380K
Common stock par value
0.0001 300,000,000...
$6K
Accounts payable and
accrued liabilities
$148,348K
Current portion of
operating lease...
$7,928K
Current portion of
long-term debt
$1,641K
Income taxes payable
$239K
Back
Back
Balance Sheet
source: myfinsight.com
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)